Pharmanutra S.p.A. (BIT:PHN)

Pharmanutra Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 2, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	521	523	542	601	730	364
Market Cap Growth	1.07%	-3.62%	-9.76%	-17.67%	100.53%	60.68%
Enterprise Value	520	523	552	595	710	350
Last Close Price	54.30	53.41	54.47	59.24	70.91	34.72
PE Ratio	29.86	31.47	42.26	39.94	53.01	25.87
Forward PE	24.58	25.25	32.36	38.79	53.54	23.04
PS Ratio	4.10	4.50	5.39	7.24	10.71	6.41
PB Ratio	7.89	8.40	9.97	11.80	16.19	9.65
P/TBV Ratio	12.51	12.79	16.38	19.87	18.30	11.18
P/FCF Ratio	50.02	32.16	-	-	47.32	35.98
P/OCF Ratio	36.09	25.50	44.85	34.41	35.76	30.85
PEG Ratio	-	1.77	1.77	1.77	1.77	1.77
EV/Sales Ratio	4.09	4.50	5.49	7.16	10.41	6.17
EV/EBITDA Ratio	16.44	17.29	21.72	24.56	36.76	23.19
EV/EBIT Ratio	18.47	19.11	24.00	25.78	38.78	24.71
EV/FCF Ratio	49.93	32.17	-	-	46.00	34.61
Debt / Equity Ratio	0.32	0.39	0.52	0.35	0.14	0.04
Debt / EBITDA Ratio	0.66	0.79	1.10	0.73	0.33	0.11
Debt / FCF Ratio	2.01	1.49	-	-	0.41	0.16
Asset Turnover	1.08	1.01	0.95	0.97	1.11	1.13
Inventory Turnover	6.81	7.53	7.76	10.13	15.13	16.15
Quick Ratio	1.60	1.95	1.70	1.96	3.08	3.39
Current Ratio	2.19	2.38	2.12	2.28	3.32	3.63
Return on Equity (ROE)	27.73%	28.39%	24.36%	31.34%	33.26%	42.73%
Return on Assets (ROA)	14.96%	14.88%	13.54%	16.82%	18.58%	17.61%
Return on Capital (ROIC)	20.67%	20.25%	19.05%	24.01%	25.18%	23.95%
Return on Capital Employed (ROCE)	31.80%	30.40%	27.20%	31.00%	33.50%	34.90%
Earnings Yield	3.35%	3.18%	2.37%	2.50%	1.89%	3.87%
FCF Yield	2.00%	3.11%	-0.21%	-1.45%	2.11%	2.78%
Dividend Yield	1.84%	1.87%	1.56%	1.35%	1.00%	1.93%
Payout Ratio	54.97%	49.20%	60.11%	45.53%	47.10%	31.64%
Buyback Yield / Dilution	0.58%	0.61%	0.05%	0.09%	-	-
Total Shareholder Return	2.42%	2.48%	1.61%	1.44%	1.00%	1.93%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.